Rupee gains as dollar slides on U.S. data backing slower rate hikes



By Anushka Trivedi

MUMBAI, Dec 2 (Reuters) - The Indian rupee rose on Friday, but gains were capped due to dollar demand amid a slump in the greenback after U.S. data overnight reaffirmed expectations of a slowdown in the pace of rate hikes by the Federal Reserve.

The rupee INR=IN edged up 0.05% to 81.1725 per dollar by 10:22 a.m. IST, and was headed towards weekly gains of 0.7%.

Oil importers sought dollars, while there was also fixing-related dollar demand by foreign banks, which likely weighed on the rupee, said a trader with a private bank.

The overall tone of the markets was quite subdued, with most Asian currencies gaining marginally and stocks declining across the board ahead of U.S. non-farm payrolls data, another big test for investors looking for signs of a shift in the Fed's monetary policy.

Indian equities .NSEI shed 0.5%, set for their first drop in nine sessions.

The dollar index =USD nursed heavy losses, having declined 1.2% overnight after the Fed's preferred inflation measure, core personal consumption expenditures (PCE) price index, softened in October.

U.S. manufacturing activity contracted for the first time in 2-1/2 years, with both datasets adding to the prospect that the Fed could opt for a 50 basis point (bps) rate hike at its next policy meeting in two weeks.

Fed Chair Jerome Powell had already signalled earlier this week that the U.S. central bank could slow its pace of rate hikes by as soon as this month.

Meanwhile, in China, sources told Reuters that Beijing is set to announce an easing of its COVID-19 quarantine rules in the coming days and a reduction in mass testing.

This was a marked shift in policy after anger over the world's toughest curbs fuelled widespread protests that fuelled worries about the country's growth and its trickle-down effect on the global economy.
Reporting by Anushka Trivedi in Mumbai; Editing by Savio D'Souza

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.